Wow. TCET Actually Happened.
Published on: 14/08/2024
A breakdown of the finalized TCET rule and what it means for Breakthrough Devices.
TCETMedicareNCDCEDEvidence DevelopmentEvidenceCMSCMS Device Nomination
AI MedTech Reimbursement: Insights from Recent Literature
Published on: 13/08/2024
A review of what peer-reviewed publications reveal about payer adoption of AI tools.
AIAI MedTechMedicarePayer CoverageEvidenceCodingArtificial intelligenceHealth Technology AssessmentHTANovelValue-basedPayer Engagement
The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival
Published on: 03/08/2024
Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.
AIAI/MLReimbursement StrategyPayerPayer EngagementProduct DevelopmentHealthcare StakeholdersClinical UtilityEvidence
Beyond Medical Policy: Different Strategies for MedTech to Engage Payers
Published on: 05/06/2024
Not every MedTech device gets written into policy. Here’s how to engage U.S. payers even when your innovation falls outside the playbook.
Payer EngagementMedical Policy GapsPre-authorizationReimbursement StrategyClaimsMarket AccessValue-based ArrangementsVBAFee-For-ServicePay-for-PerformanceP4Pthird-party administratorsTPACost-Effectiveness AnalysisCenters of ExcellenceCOEReal-World DataRWDEvidencePayersPatient Advocacy GroupsDirect-to-ConsumerD2C
